You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSK-390

Showing 1 - 25 of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2021

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)

Active, not recruiting
  • Glioblastoma Multiforme
  • Anaplastic Glioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 29, 2020

Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

Completed
  • Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 15, 2021

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,

Completed
  • Medulloblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Los Angeles, California
  • +14 more
Jan 12, 2022

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma

Completed
Has Results
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • +11 more
  • Duarte, California
  • +11 more
Jul 14, 2020

AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States

Completed
Has Results
  • AIDS-Related Plasmablastic Lymphoma
  • +15 more
  • Montgomery, Alabama
  • +34 more
Feb 23, 2022

Musculoskeletal Diseases or Conditions Trial (Educational Tool)

Not yet recruiting
  • Musculoskeletal Diseases or Conditions
  • Educational Tool
  • (no location specified)
Jun 19, 2023

Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston

Not yet recruiting
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2020

Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

Active, not recruiting
Has Results
  • Brain Stem Glioma
  • +4 more
  • Bevacizumab
  • +2 more
  • Birmingham, Alabama
  • +136 more
Oct 15, 2022

Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial

Active, not recruiting
Has Results
  • Ann Arbor Stage II Non-Hodgkin Lymphoma
  • +2 more
  • Mobile, Alabama
  • +189 more
Jan 28, 2023

Chronic Back Pain, Depression, Aging Trial in Dallas (Behavioral Intervention Group (MOTIVATE))

Not yet recruiting
  • Chronic Back Pain
  • +3 more
  • Behavioral Intervention Group (MOTIVATE)
  • Dallas, Texas
    VA North Texas Health Care System Dallas VA Medical Center, Dall
Jan 31, 2023

Carcinoma, Transitional Cell Trial in Worldwide (Atezolizumab)

Terminated
Has Results
  • Carcinoma, Transitional Cell
  • Scottsdale, Arizona
  • +185 more
Jun 13, 2022

Parkinson's Disease Who Previously Received BRT-DA01

Enrolling by invitation
  • Parkinson Disease
    • New York, New York
      Weill Cornell Medical College
    Jun 1, 2023

    Smart Community Rehabilitation

    Recruiting
    • Musculoskeletal Diseases
    • Exercise and Social Groups
    • Oxford, United Kingdom
      Oxford Brookes
    Mar 9, 2022